CTOs on the Move

Allergy and Asthma Care

www.allergymemphis.com

 
Allergy and Asthma Care is a Germantown, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

GlobalTox

GlobalTox is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dr.Contact Lens

The easiest way to order contacts on the planet!

White Healthcare Center Inc

Tealwood Care Centers, Inc. was formed in January 1989 as a long term care, for-profit company, dedicated to serving the needs of skilled nursing facility residents. Our goals go beyond taking care of the resident's needs in a safe and comfortable

Behavioral Health Services

Since 1973, Behavioral Health Services, Inc. has prided itself on providing a continuum of substance abuse treatment services. Each of our programs is based on the philosophy that recovery from addiction is a life-long process.

Alnylam

Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.